The FDA will allow several new nicotine pouch products to be marketed as a "lower-risk option" compared with cigarettes.

Patients with dementia and agitation are more likely to transition to a more supportive living setting after psychiatric hospitalization.

Supplementation with high-dose docosahexaenoic acid does not improve or change cognitive performance or brain volume over 24 months.

Inadequate built and social environments from birth through childhood may increase the likelihood for depression and anxiety in adolescence.

The Real Cost campaign successfully prevented youth from initiating e-cigarette use and reduced unauthorized sales.

Improved maternal cardiovascular health is associated with a reduced risk for developmental delay among children at age 4 years.

The US Department of Health and Human Services Office of Inspector General reports on significant denial rates for post-hospital care.

A new digital mindfulness intervention reduces sleep, anxiety, and depression symptoms among people with late-life depression.

School bullying correlates with depression and internet addiction, but emotional resilience serves as a protective factor for adolescents.

Telehealth-based stepped alcohol treatment is effective for reducing alcohol consumption among people with chronic liver disease.

Long-term eptinezumab treatment provides sustained reductions in headache burden for patients with highly refractory chronic migraine.

Comorbid ASD in youth with ADHD is linked to greater healthcare utilization and distinct medication treatment patterns.